Because a pharmaceutical company cant monetize it because theres no patent on it, so I dont know when were ever going to get the real truth on this thing, because nobodys putting billions of dollars into researching it, because nobodys going to monetize it
Its versatility makes it a key tool in preclinical studies investigating tissue recovery and structural health
In some cases, physical therapy, pain management, or even surgical intervention may be required to address long-term complications
Injection site reactions including temporary redness, swelling, or itching occur occasionally
BPC-157 is a synthetic pentadecapeptide stabilised against acid hydrolysis, acting through multiple receptor systems including VEGFR2, FAK (focal adhesion kinase), EGR1 (early growth response protein 1), and eNOS to produce angiogenesis, tissue repair, anti-inflammatory, and neuroprotective effects
My personal experience of being told by some doctors I'm now sorted as B12 replete so no longer b12 deficient is incorrect